Research and treatments
Latest news on clinical and scientific research in endometriosis.
What are the facts behind the headlines about endometriosis and risk of ovarian cancer?
DNA from 60,600 women with endometriosis reveals evidence of shared genetic basis for endo and other causes of pain.
Researchers have identified a specific gene (NPSR1) that increases risk of suffering pain from endometriosis with a potential new non-hormonal drug target that may lead to improved therapies in endometriosis.
Researchers at Aarhus University head up a major international research and innovation project aimed at improving treatment and quality of life of those affected by endometriosis. Machine learning and artificial intelligence will contribute to this!
A history of intense exposure to the sun may increase risk of being diagnosed with endometriosis over time.
We need to dispel myths that the prevalence of endometriosis differs in women of different racial/ethnic groups.
Immune cells called macrophages could play a key role in the generation of pain in endometriosis according to research at University of Warwick and University of Edinburgh.
A blood test claiming to diagnose endometriosis with a ninety percent accuracy will be launched within a year. But is it all that it is cracked up to be?
Development of low-invasive tests/biomarkers for endometriosis remains a high priority in improving the diagnosis, management, and prognosis (progression/regression) of endometriosis. To date there are no reliable / validated tests.
Hysterectomy does not guarantee a relief from endometriosis-related symptoms and can neither be classified as a “treatment”, nor as a “cure” for endometriosis; it may relieve co-existing adenomyosis.